The pursuit of market outperformance leads investors to the practice of hand-picking stocks. Skillful choices can be a catalyst for significant wealth enhancement.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The closing price of Akero Therapeutics Inc (NASDAQ: AKRO) was $35.28 for the day, up 7.76% from the previous closing price of $32.74. In other words, the price has increased by $7.76 from its previous closing price. On the day, 0.84 million shares were traded. AKRO stock price reached its highest trading level at $35.705 during the session, while it also had its lowest trading level at $33.46.
Ratios:
Our analysis of AKRO’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 24.89 and its Current Ratio is at 24.89. In the meantime, Its Debt-to-Equity ratio is 0.05 whereas as Long-Term Debt/Eq ratio is at 0.04.
On September 19, 2023, Cantor Fitzgerald started tracking the stock assigning a Overweight rating and target price of $69.
On August 28, 2023, UBS started tracking the stock assigning a Buy rating and target price of $83.UBS initiated its Buy rating on August 28, 2023, with a $83 target price.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Nov 06 ’24 when CATRIONA YALE bought 10,000 shares for $32.74 per share.
Young Jonathan sold 50,716 shares of AKRO for $1,601,252 on Nov 01 ’24. The Chief Operating Officer now owns 216,286 shares after completing the transaction at $31.57 per share. On Nov 01 ’24, another insider, Cheng Andrew, who serves as the President and CEO of the company, sold 108,366 shares for $31.73 each. As a result, the insider received 3,438,312 and left with 605,417 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, AKRO now has a Market Capitalization of 2449518592 and an Enterprise Value of 1725235968.
Stock Price History:
Over the past 52 weeks, AKRO has reached a high of $37.00, while it has fallen to a 52-week low of $13.39. The 50-Day Moving Average of the stock is 22.90%, while the 200-Day Moving Average is calculated to be 42.44%.
Shares Statistics:
AKRO traded an average of 495.48K shares per day over the past three months and 562810 shares per day over the past ten days. A total of 69.43M shares are outstanding, with a floating share count of 58.10M. Insiders hold about 16.31% of the company’s shares, while institutions hold 98.25% stake in the company. Shares short for AKRO as of 1728950400 were 4715504 with a Short Ratio of 9.52, compared to 1726185600 on 7163232. Therefore, it implies a Short% of Shares Outstanding of 4715504 and a Short% of Float of 6.99.
